Cell Therapy

The fundamental challenge of modern oncology lies in sustaining the vigilance of chimeric antigen receptor T cells once they enter the hostile terrain of a solid tumor environment. While these engineered immune cells have demonstrated remarkable success in treating liquid cancers like leukemia,

The biological landscape of modern oncology is currently undergoing a radical transformation as researchers attempt to outmaneuver the inherent ability of cancer cells to evolve and survive aggressive therapeutic interventions. At the forefront of this shift is the Wellcome Sanger Institute, a

The landscape of modern cancer treatment is currently undergoing a seismic shift as the results from the 2024 American Society of Clinical Oncology meeting continue to permeate clinical practice and pharmaceutical strategy. This annual gathering in Chicago served as the primary stage for unveiling

The persistent burden of sickle cell disease has historically defined the lives of millions through a cycle of debilitating pain and systemic health complications that frequently lead to premature mortality. For decades, the medical community struggled to provide more than palliative care, as the

The pursuit of a definitive solution for treatment-resistant neurological disorders has reached a critical juncture at the University of Miami Miller School of Medicine through its leadership in the BEAT-MS clinical trial. Formally recognized as the ITN077AI study, this Phase 3 multicenter,

The long-held biological dogma that gene-editing machinery must rely on fragile RNA strands to find its target has finally been dismantled by a pioneering shift toward DNA-guided navigation. For years, the scientific community accepted the inherent instability of RNA as a necessary trade-off for